IGC Pharma Announces Equity Research Update by Alliance Global Partners

robot
Abstract generation in progress

IGC Pharma, Inc. (NYSE American:IGC) announced that Alliance Global Partners (AGP) has published an updated equity research report. The report reiterates a Buy rating for IGC Pharma and sets a price target of $3.00 per share. IGC Pharma emphasizes that the report’s views are solely those of the analysts and not endorsed by the company.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)